cial issue thus contributes to a line of research in professional communication that investigates the ways "discourse is related recursively to social practice and institutions . . . recogniz [ing] it as contingent and ideologically interested" (Herndl, 1993, pp. 353-354) . In his original article calling for this line of research, Herndl (1993) critiqued research methods that retain a "limited, descriptive research in professional writing . . . [that] describes the production of meaning but not the cultural work such discourse performs" (p. 351). One of the ways in which research methods can be limited is by not recognizing the multiple connections between discourse and social, material, institutional, and cultural structures:
A theory of discourse adequate to professional writing research should also recognize that no discourse is uniform: all professional, institutional, or disciplinary discourses are crossed by a number of competing interests and positions. . . . Similarly, the institutions which are the sites of cultural production always contain multiple and competing interests; cultural and ideological power are not monolithic. (Herndl, 1993, p. 354) Herndl and Nahrwold (2000) later argued that "the majority of [research in professional communication continues] to be descriptive, amassing carefully detailed studies of rhetorical activity . . . [that] rarely examine or criticize the ideological interests of the institutions and workplaces it studies" (p. 271). In continuing to call for this kind of research, however, Herndl and Nahrwold noted that "the difficulty with such programs . . . is how to avoid a kind of theoretical imperialism that unilaterally imposes the researcher's theoretical agenda on the situation and participants" (p. 279). One answer they posed to this problem, again, is to acknowledge the multiple connections between research data and its analysis, critique, and theorization. They suggested that research work toward "the task of producing a useful and adequate account of social activity that both researchers and their audiences will accept as valid" (p. 283). In this way, "studies of technical and professional communication that emerge from [a more critical position will] examine the consequences of communication practices for members of organizations, for the clients of organizations, or for social relations at large" (p. 279).
One of the strengths that the field of professional communication brings to the investigation of professions and their institutional and cultural practices is its careful and critical attention to language and the ways that discourse practices recursively create and reflect profes-sions in multiple ways. In this article, I attempt to work methodologically toward a theoretically robust combination of careful and critical attention to the language and discourse of professional communication. I develop an argument for the methodological contributions of a set of linguistic methods that are known more for their careful descriptive work than for their potential for critical analysis. Specifically, I argue that a combination of recent work in genre theory, genre analysis, and discourse analysis can be used to uncover the multiple connections between discourse practices and their underlying concepts and categories within professions, what early linguistic ethnographers such as Pike (1967) and Hymes (1972) called emic categories. Emic categories, broadly defined, are categories that are internal to the culture or group being studied, in contrast to etic, or external, categories that a researcher might bring to an analysis. The term emic has become more contested of late: Agar (1996) , for instance, spoke of the disappearing line between emic and etic, but I use emic here to refer roughly to categories that are part of the collective sensibility of a profession. By orienting work in discourse studies toward the multiply determined emic categories that underlie professional practices, researchers can lay a solid basis for critical analysis and theorizing that looks simultaneously to the profession itself as well as the researcher's critical perspective on that profession.
The particular discourse I consider here is that of medicine, a discourse that serves as an exemplar of Herndl and Nahrwold's (2000) observation that the task of developing a critical account that is satisfying to rhetorical researchers as well as medical practitioners is "vexed" (p. 279). Segal, Paré, Brent, and Vipond (1998) have written of the difficulty in presenting critically informed research to medical audiences that resist, reject, or ignore the analysis as well as the suggestions for change. Some of the resistance to critical research may arise from the tendency of such research toward theoretical imperialism, as suggested by Herndl and Nahrwold, although I have argued that resistance might also stem from differences between disciplinary and interdisciplinary questions (Barton, 2001 ). Segal et al., however, wisely suggested from their experience that "we must learn to talk with scientists and practitioners in other disciplines. . . . Our projects will fare better if we acknowledge disciplinary complexity" (pp. 82-84) . I argue here that discourse-based methods can better connect critical analysis and theorizing to the emic concepts and categories of professions and that such discourse-based theorizing can lead to rhetorical researchers and medical practitioners developing a mutually accept-able understanding of the discourse practices of the profession. I illustrate this theoretical and methodological project with an analysis of a particularly problematic aspect of the discourse of medicine-presenting a prognosis to a patient who has a serious disease.
After introducing Goffman's (1959) theoretical construct of front stage and back stage and briefly reviewing the literature in genre theory, genre analysis, and discourse analysis, I develop a genre analysis of the treatment discussion in medical oncology encounters. In the genre analysis I focus on three key steps: foregrounding diagnostic information, presenting treatment information, and asking questions. I argue that the genre of treatment discussion is a coconstruction of interested parties. Next, I pose a key question for discourse analysis: What is the status of prognosis in the treatment discussion? In response, I argue that the genre of treatment discussion is organized to allow physicians to do, not do, or appear to do the difficult work of presenting prognoses. Then, I pose a series of critical questions about the multiple connections between the discourse of prognosis and the emic categories of the medical profession. I conclude by arguing that discourse-based methods provide a productive basis for critical engagement between researchers in professional communication and practitioners in medicine.
THEORETICAL AND METHODOLOGICAL FRAMEWORKS
In his first book, the ethnomethodologist Goffman (1959) drew a theoretical distinction between front-stage and back-stage regions. On the front stage, individuals deliver performances to an audience: "The performance of an individual in a front region may be seen as an effort to give the appearance that his activity in the region maintains and embodies certain standards" (p. 107). The back stage, however, is a region for insiders:
[In the back-stage region,] suppressed facts make an appearance. . . . A back-stage may be defined as a place, relative to a given performance, where the impression fostered by the performance is knowingly contradicted as a matter of course. . . . Here the performer can relax; he can drop his front, forgo speaking his lines, and step out of character. . . . One of the most interesting times to observe . . . is the moment when a performer . . . returns [from the front-stage region], for at these moments one can detect a wonderful putting on and taking off of character. (pp. 112-128) Goffman noted several times that the front-stage/back-stage distinction characterizes institutional encounters well. For an example, he referred to one of the earliest ethnographies of medicine, Boys in White (Becker, Geer, Hughes, & Strauss, 1961) . Even today, this distinction captures situations of observational and ethnographic research on the discourse of medicine in a powerfully intuitive way: On the front stage in a clinical encounter, physicians and other medical staff deliver the professionalized discourse of medicine; on the back stage in the hallway or clinical work area, these same professionals talk as coworkers, coconstructing an insider discourse of medicine that covers a variety of medical and nonmedical topics.
As a heuristic for research on the discourse of medicine, Goffman's (1959) distinction implies that we might look with interest at matters treated differently on the front stage with patients and families than in the back stage with coworkers (and researchers). To illustrate, on my first day in an academic cancer center, I was observing only, not yet recording, with Dr. T; as we left the clinic room of the first patient, he turned to me and said, "Her liver is huge." Hazarding a guess based on my sketchy knowledge of oncology, I responded, "That's not good, is it?" This hallway exchange seemed to be addressed to me as a backstage insider, albeit, as my response showed, a somewhat tentative one, so I decided to begin collecting these hallway exchanges with a vague idea of trying to understand how these back-stage exchanges characterized the relationships between physicians and researchers. As it turned out, however, the topic of this exchange-prognosispointed to a more important subject for analysis. In this article, I argue that the back-stage attention to prognosis points to its problematic status in the front-stage discourse of encounters between medical oncologists and patients diagnosed with cancer.
The front-stage presentation of prognosis is the performance of an oral genre in the discourse of medicine: It is a repeated and recognizable stretch of discourse in medical oncology encounters, and its discourse is multiply determined by complex and conflicted emic categories of the profession. In Miller's (1984 Miller's ( /1994 seminal terms, a genre is a response to a particular exigence:
Exigence must be located in the social world. . . . Exigence is a form of social knowledge-a mutual construing of objects, events, interests and purposes. . . . It provides the rhetor with a socially recognizable way to make his or her intentions known. It provides an occasion, and thus a form for making public our private versions of things. (p. 30) Miller thus connected genre as "a complex of formal and substantive features" to genre "as a form of social action" (p. 25). Extended to describe institutional encounters, this description points to the interaction of professional expertise and its delivery in generic forms, on the front stage, as Goffman (1959) would remind us.
Work in genre theory has shown how genres play a crucially important bridging role between the situated discourse practices of individuals and the instantiation of the institutional and social actions of professions and organizations (Bazerman, 1994; Berkenkotter & Huckin, 1995; Devitt, Bawarshi, & Reiff, 2003; Paré & Smart, 1994; Russell, 1997; Smart, 1993; Winsor, 1999 Winsor, , 2000 ; for an excellent review and application of genre theory to medical discourse, see Schryer, Lingard, Spafford, & Garwood, 2003) . Much of this work, however, has focused on written genres, and the genre theory literature often includes a statement that essentially equates oral and written modes: Berkenkotter (2001) , for example, noted, "Text here refers to . . . spoken, written, and electronically-mediated discourse" (p. 330). In this article, however, I argue that the use of oral genres raises important questions about professional practices, particularly in institutions where professionals do and deliver their work through talk as well as writing. Medicine is one such profession with a distinctly oral character, with its delivery system of front-stage medical encounters between physicians and patients and their families. In the discourse of medicine, the presentation of prognosis is always performed on the front stage and delivered orally during the treatment portion of an encounter. This method of presentation raises Becker's (1995) critical question for discourse analysis: Why is this text arranged this way and no other way? For the purposes here, we could paraphrase: Why is this text, this genre, an oral one?
Although Dannels (2003) noted that "research on oral genres has been slow to emerge" (p. 142), the forthcoming literature in genre analysis has turned its attention to oral genres, particularly in the work of Swales (in press). Reviewing recent work in genre theory, particularly that of Bazerman (1994) , Swales argued that genre analysis, too, must widen its methodological scope to move from the analysis of single genres, like the research article, to the analysis of genre hierarchies, genre chains, and genre networks. Following this approach, he looked at the organization and features of a variety of oral genres in academic research, such as the dissertation defense, research group meetings, colloquia, and conference presentations. Each of these genres provides a different answer to the questions of how and why an oral genre seems to serve the purposes of different contexts, but Swales also tentatively proposed a general answer to the question of why an oral genre is used: In the academic research world, oral genres are characterized by an "open style," a style that is technical to the discipline but also more informal, evaluative, oriented toward consensus in a social situation, and focused on the emerging claims of new work. An oral research genre, Swales noted, is "a considerable rhetorical achievement as it attempts to depict both recalcitrant problems and tenuous solutions" (chap. 6).
In this article, I propose a different answer to the critical question of why certain discourses are organized as oral genres in medical discourse and perhaps other professional discourses. I argue that oral genres allow a practitioner to do, appear to do, or avoid doing difficult work. Specifically, I use a combination of genre analysis and discourse analysis to argue that the organization of oral genres allows users to foreground, background, or omit certain kinds of difficult-todeliver information, such as prognosis.
A GENRE ANALYSIS OF TREATMENT DISCUSSIONS IN MEDICAL ONCOLOGY
This research is based on my observational fieldwork in a comprehensive cancer center in a large midwestern city. I gathered data for a genre analysis of front-stage treatment discussions from a corpus of 12 transcribed encounters with four physicians in four oncology clinics: melanoma, lung, sarcoma, and GI (gastrointestinal, primarily colon cancer). The physicians were all male, three white Americans and one foreign national from India. One of the physicians served as my physician informant on the project, providing medical information, discussing emerging ideas and analyses, and commenting on preliminary drafts of research articles (Barton, 2002) . The patients were a mix of genders, races, and socioeconomic statuses, from centralcity residents with no insurance using the city hospital to urban, suburban, and exurban residents with blue-chip insurance and considerable sophistication about academic medicine. In deference to the serious and distressing circumstances of patients who have been given a recent diagnosis of cancer, I chose not to ask patients I observed in the cancer center for their response to this work; instead, I asked the family of a patient who was treated a year ago to serve as my family informants and comment on a draft of this article (Barton, 2002) .
Patients are referred to medical oncologists at different points during diagnosis and treatment, depending on the pattern of particular cancers. Melanoma and colon cancer patients are usually referred to a medical oncologist for evaluation and treatment after surgery. Lung cancer and sarcoma patients are most often referred directly to a medical oncologist after diagnosis; the oncologist then refers the patient to a surgeon if the cancer is operable before or during treatment.
The cancer center schedules appointments for new patients under a separate, named category, allotting a full hour for the appointment. These oncology encounters with new patients have an elaborate and identifiable generic structure, a chain of genres within a distinct hierarchy. Typically, patients and families arrive at the cancer center, check in, hand in any records or films they have brought with them, and then wait in the nicest waiting room in the hospital, complete with a contemplative fish tank and an automated grand piano. Brought into a small and spare clinic room by a patient-care aide who takes vital signs and records them on a form called the Patient Flow Chart, the patients are then seen by a nurse, whose main contribution to the rest of the encounter is to ascertain a list of the patient's current medications and record it on a Nursing Assessment form. Patients are then seen by an oncology fellow (a physician in advanced training in oncology) or a physician extender (either a clinical nurse specialist or a physician assistant specializing in oncology). Fellows and extenders take the patient's general medical and social history, following a standard History and Physical form, as well as a detailed history of the patient's cancer, using a large blank space on the same form to take notes for a case presentation to the attending physician. They also perform a physical exam, again following the standardized form and format of medicine. The discourse of the initial portions of the encounter, then, is a form-driven interview genre in an asymmetrical questionand-answer (Q-A) exchange structure, familiar in the research literature on the discourse of medicine (Fisher & Todd, 1993; Mishler, 1984;  for accounts of the ways that forms drive the genres of a medical encounter, see Berkenkotter, 2001; McCarthy, 1991; McCarthy & Gerring, 1994; Reynolds, Mair, & Fischer, 1995; Schryer et al., 2003) .
The portion of the medical oncology encounter devoted to treatment, however, is the domain of the oncology physician, and multiple discoursal, contextual, material, and interactive features indicate that the top of the generic hierarchy has been reached. First, within the discourse of the previous phases of the encounter, nurses, extenders, and even oncology fellows systematically deflect all discussion of treatment to this portion of the encounter. For example, when one patient with colon cancer reported during the history and physical that she had been told she would not need chemotherapy, the extender overtly deflected the topic and continued taking her medical history in standard Q-A format: The treatment portion of the encounter is made contextually significant in that the attending oncologist is typically the last medical professional to make an appearance; that is, the patient has been seen by medical professionals in ascending order according to their degree of specialized training. The treatment portion of the encounter is materially significant in that it determines the specific plan for patient care, which can range from observation and screening (sometimes called watchful waiting) to complicated chemotherapy and radiation regimens. The treatment portion of the encounter incorporates both presentational and interactional discourse but is, by far, the most interactive portion of the entire encounter. At this time, physicians, support staff, patients, and families participate in shared decision making, a discourse that ideally is based on the interactional involvement of all parties, and some patients and families have many questions (sometimes a list) for "the doctor," as they often say with a ritualistic acknowledgment of power and authority. A genre analysis of the treatment discussion in medical oncology aims to identify recurring moves and steps. Bhatia (1993) The structural organization of the genre of treatment discussion in medical oncology consists of four major generic moves with accompanying steps, as shown in Table 1 . In all four moves, steps vary: Sometimes steps such as background information or invitation to trial are skipped entirely or are elaborated minimally or maximally; in Moves 2 and 3, the order of steps varies. Moves 1, 2, and 3, however, each have an identifiable key step. I discuss these three crucial steps in the following subsections in terms of their importance in the frontstage presentation of prognosis. 
Move 1
In Move 1, physicians often begin by providing some background information about the patient's disease, but the amount of background information varies considerably, from a detailed discussion to a brief sentence. The physician's key step in Move 1, however, is to explicitly state the stage of the cancer:
Excerpt 2a
Physician: When we look at this, based on the information we got, you would be what we call Stage IIIB.
Excerpt 2b
Physician: The margins were negative, and nodes were negative, pretty much all the way to the wall, but I call it a Stage IIB just because it went through the wall. But, it's still in an early stage.
Excerpt 2c
Physician: But, let's look at the best scenario here with your case, and that's Stage III because I do not have evidence of the disease anywhere else.
Because treatment is specific to the stage of different types of tumors,
Step 2 of Move 1 functions to foreground the most relevant aspect of the diagnosis for treatment. Within the treatment discussion as a whole, Move 1 functions to foreground the relevant piece of diagnostic information by using a generalized version of the medical terminology of cancer staging. The full vocabulary of tumor staging is elaborate and specific to types of tumors (Calabresi, Schein, & Rosenberg, 1985; DeVita, Hellman, & Rosenberg, 1985) . The version of staging vocabulary physicians use in their treatment discussions with patients and their families, however, includes just four category labels-I, II, III, and IV-with some physicians further dividing these main stages into A or B substages. In this combined professional-lay discourse, Stages I and II are generally considered early stages of the disease, and Stages III and IV are generally considered advanced stages, with Stage IV considered incurable:
Excerpt 3a
Physician: I call it a Stage IIB just because it went through the wall. But, it's still in an early stage.
Excerpt 3b
Physician: There's four stages of lung cancer, I, II, III, and IV. IV being it's spread outside the chest, and that's bad. We usually don't cure those. Stage IIIB is the next stage below Stage IV, and it still represents a problem. It's a challenge to get rid of it.
Excerpt 3c
Physician: But if the melanoma spreads beyond the regional lymph nodes, the other areas of the body, or is to the point where it can't be removed surgically, it's generally to you guys Stage IV melanoma, and it's not viewed as a curable form of cancer.
Features of these examples show physicians' awareness of their use of staging labels as a lay vocabulary. In excerpt 3a, the physician further generalizes Stage IIB as an early stage; in excerpts 3b and 3c, the physicians describe Stage III as advanced disease and Stage IV as incurable. In 3c, the physician explicitly signals the lay status of the term Stage IV melanoma with his prefatory remark generally to you guys. The performance of Step 2 in Move 1, then, means that a patient does not simply have colon cancer or lung cancer or melanoma anymore; the patient has Stage IIB, Stage III, or Stage IV cancer. The use of staging vocabulary is thus a sort of identity labeling-the patient is given a specific identity for cancer treatment. Within the overall course of a patient's "medical career," as Talcott Parsons (1951) would call it, Move 1, Step 2 is a key step in the generic chain of medical encounters that are integral to the patient's cancer treatment.
By using a lay version of professional terms to label the degree of progression of the patient's disease, however, physicians actually provide patients with a vocabulary that has no clear relationship with the medical literature (and therefore the expertise) of the profession. For example, if patients or family members want to learn more about Stage II disease by visiting the National Cancer Institute's Web site (http://www.nci.nih.gov), they would find no match to Stage II in querying the Web site's search engine. Similarly, if patients went to the library to find standard medical texts on cancer (Calabresi et al., 1985; DeVita et al., 1985) , they would find no index entry under the general term Stage II. Only if individuals are canny enough to identify the type of disease (e.g., lung cancer) before searching for staging information would they find a detailed description of stage labels. What they would also find in that description, however, is a connection between staging and prognosis, a connection that physicians had made but not foregrounded in any substantive way in excerpts 3a, 3b, and 3c. The laicizing of terminology, then, may seem an appropriate way to make the disease label more specific and meaningful for patients and families, but it actually obscures the connection between staging and prognosis that is central to the professional expertise.
Move 2
In Move 2, the physician presents treatment information-the central purpose of the initial encounter in medical oncology. The key step in presenting this information is to explicitly describe the treatment modality for a particular type and stage of cancer-chemotherapy, radiation therapy, surgery, biological therapy, or a combination of these therapies. The treatment recommendation is usually the first step in Move 2:
Excerpt 4a
Physician: Now, what it [treatment] involves is getting chemotherapy and radiation together.
Excerpt 4b
Physician: Based on that [studies about chemotherapy and Stage II colon cancer], we do not routinely offer chemo.
Excerpt 4c
Physician: And in that situation, what we do is we do the chemotherapy and the radiation together.
Excerpt 4d
Physician: In general, we would recommend some form of chemotherapy. The standard of care.
Excerpt 4e
Physician: In general, there are two forms of therapy that are generally offered here in the United States in treatments, and they're both drug types of treatments. One is chemotherapy, and the other is referred to as biotherapy.
The treatment recommendation is the most materially significant statement within the genre: It establishes the overall mode of treatment.
As in
Step 2 of Move 1, the delivery of information and the expertise of the profession are critically connected. In Move 2, the critical connection comes from the sentence-level framing of the treatment recommendation; the recommendation is rarely presented without some kind of framing, as in excerpt 4a. Usually, the treatment recommendation is framed within a claim to authority-either the authority of current medical research (e.g., based on studies) or the authority of good clinical practice (e.g., the standard of care, in that situation, in general, and here in the United States). This sentence-level framing often includes the institutional pronoun we. The use of we frames the treatment recommendation squarely within the expertise of the profession of medicine as well as the clinical practice of the cancer center.
Move 3
The end of Move 2 usually initiates the beginning of interactional discourse in Move 3 of the genre. Sometimes physicians overtly signal the opportunity for interaction: 
Excerpt 5b
Physician: Do you have any questions right off the bat?
But more often, the physician comes to the end of Move 2 and pauses, and families begin posing a series of questions, sometimes working from a list. One specific kind of question in Move 3 is particularly relevant to prognosis-questions that directly address the previous moves and steps in the treatment genre. Thus, Move 3 can be seen as an interactional opportunity for physicians and patients and their families to coconstruct a full version of the treatment genre: If a step has not been mentioned or executed satisfactorily in previous discourse, patients, families, and sometimes physicians themselves address it in Move 3 via interactional discourse. For example, patients and families usually ask about side effects if they have not been mentioned or fully discussed in Move 2. In the following exchange, the physician signals the end of Move 2 and the beginning of interaction in Move 3, and the patient's first question concerns side effects: Occasionally, questions refer all the way back to Move 1, with queries about background information and the original diagnosis of cancer:
Is this normal, for me to be walking around, doing everything fine, and then all of a suddenPhysician: And suddenly you have this cancer? Yes, this is very common. Patient:
I had X-rays three years ago. Physician: Three years ago they would have been negative. Six months ago, they probably would have seen something small in there. But you didn't have any symptoms then. Your story is extremely typical for lung cancer. I was minding my own business, then one day I had a few symptoms, and I saw the doctor, and they said not only do you have cancer, but it's pretty far advanced. Very common story for lung cancer. About 8 out of 10 people with lung cancer present with Stage III or IV. That's just the way it behaves. When it's a little spot, no one-You don't know it's therePatient:
Well, that puts me at ease a lot. I thought I did something wrong.
It is not unusual for patients or family members to express satisfaction with receiving answers to their questions, as in excerpt 7. Questions in Move 3 address a wide range of topics, some relating to Moves 1 and 2, such as background information, staging or diagnosis, treatment recommendations, side effects, treatment plans, and clinical trials, and others concerning matters such as possible interactions with medications for other conditions, diet, nutritional supplementation, and family support. Still other questions anticipate Move 4-arranging treatment-and address concerns about logistics, such as facilities, appointments, times, and parking.
In sum, through presentational and interactional discourse, physicians, patients, and their families coconstruct a full version of the genre of oncology treatment discussions, thereby making the genre an interactional achievement with contributions from multiple parties. Physicians, patients, and their families, then, can all be considered users of this genre in medical oncology encounters.
A DISCOURSE ANALYSIS OF PROGNOSIS
But what is the status of prognosis in this genre of treatment discussions? Prognosis is defined in medical dictionaries as the probable course or outcome of a disease and the patient's chance of recovery (Chabner, 1996) . Intuitively, prognosis would seem to be an important part of any treatment discussion-in genre analysis terms, certainly a step and perhaps even a move. Prognosis was certainly a prominent topic in back-stage conversation, as I will show later. Counterintuitively, however, the front-stage presentation of prognosis varied widely across the corpus, not coalescing into a recognizable move or step within the genre of the treatment discussion although the specific features of prognosis were identifiable across the corpus. In the following subsections, I develop a discourse analysis of the presentation of prognosis in treatment discussions on the front stage between physicians, patients, and their families and on the back stage in conversations between physicians, researcher, and staff.
Front-Stage Prognosis in Treatment Discussions
A discourse analysis of the corpus revealed that presenting a prognosis was not a predictable move in the genre of treatment discussions. Of the 12 encounters I observed, 4 contained no physicianinitiated mention or discussion of prognosis at all, indicating that presenting a prognosis does not have a consistent status in the genre in the same way as do foregrounding diagnostic information (Move 1), presenting treatment information (Move 2), asking questions (Move 3), and arranging treatment (Move 4), all of which occurred in every encounter. Furthermore, in the eight encounters that included physician-initiated mentions or discussions of prognosis, the point at which the subject of prognosis was broached varied, indicating that prognosis does not have a consistent status as a step within a particular move in the genre. Of these eight encounters, three included a prognosis in Move 1, Step 2, along with staging information; four in Move 2, Step 1, with the treatment recommendation; and one in Move 2, Step 3, with the treatment plan.
My general claim in this article, then, is that the organization of the genre of treatment discussion allows physicians to do, appear to do, or avoid doing the difficult task of presenting a prognosis on the front stage of medical oncology encounters. We can see evidence for this claim in the ways physicians avoid, foreground, background, and answer questions about prognosis.
Avoiding prognosis. Omitting prognosis is not the same as avoiding it. In the four encounters that contained no physician-initiated discussion of prognosis, three were with patients who were not definitively diagnosed or staged, so in these cases, not presenting a prognosis was appropriate based on lack of information. Furthermore, in the fourth encounter, the presentation of prognosis may simply have been delayed, not avoided. But this encounter with a staged patient does provide evidence supporting my general claim that the lack of a generic move or step for presenting prognosis in the organization of the treatment discussion allows physicians to avoid prognosis altogether in the front stage of encounters that might reasonably call for this information.
Although I cannot argue directly that a physician deliberately avoided presenting a prognosis, the analysis of one encounter offers some evidence that prognosis in this case was both known and foregrounded in the physician's perspective without appearing in the front-stage discourse of the encounter. First, consider the compressed discussion of the staging information (Move 1, Step 2), treatment recommendation (Move 2, Step 1), and beginning of the treatment plan (Move 2, Step 3) in this excerpt:
Excerpt 8: Physician: When they did the liver biopsy in March, it showed that there were multiple lesions of the liver. And that means that we can't cut it out. It has to be treated by some sort of chemotherapy to try to control it. Now, we have a number of different drugs that we use for that kind of treatment.
Both the staging information and the treatment recommendation are indicated, but the staging information in the first two sentences does not explicitly state that metastasized colon cancer that cannot be surgically removed is Stage IV disease. And the treatment recommenda-tion (it has to be treated by some sort of chemotherapy) ends with the euphemistic expression to try to control it, an expression that provides no specific information about prognosis to a lay person (in fact, in the insider discourse of medicine, the expression to try to control a tumor carries the unmistakable implication of incurable disease, but I do not believe this implication is shared by the general population). Furthermore, in the back-stage talk immediately after this encounter, the physician and I had the following exchange in the hallway: Again, I must emphasize that the physician may have been simply delaying presenting a prognosis because the patient had an unhealed surgical incision and could not actually start treatment for several weeks. But by not discussing prognosis on the front stage yet immediately discussing prognosis on the back stage, the physician could be seen as avoiding the delivery of a poor prognosis. Whether the physician was avoiding presenting a prognosis or simply delaying it, however, this encounter shows how the structure of the genre, organized without a specific move or step for prognosis, allows prognosis to be omitted or avoided in the front-stage treatment discussion. Patients and families, too, can interactively construct the genre of treatment discussion to omit or avoid prognosis. In one encounter in the corpus, the wife of a patient used the opening of the treatment discussion for that purpose: "These are our children, [Randy] and [Dave] . You can tell them anything, but we don't want anything about prognosis." One of my family informants concurred with that position: Avoiding prognosis, he noted, "happens with the complete complicity of patients" (Barton, 2002) .
Foregrounding prognosis. The structure of the treatment genre is also organized to allow physicians to foreground prognosis. In the eight encounters that mentioned a prognosis, only two physicians initiated an overt and substantive discussion, but these two cases provide a preliminary description of the features of presenting a prognosis in a treatment discussion. The first encounter came after the treatment recommendation in Move 2, Step 1: Uh-huh. Physician: That obviously means that there's a 75% chance that this won't be cured. That doesn't mean we won't be able to control it, but we might be able to shrink it but not completely eliminate it. And at some point, it will come back. Before we start, let's say there are 10 patients like you, I said 25%, so three patients might get cured. Seven patients are not going to get cured. Before I start, I don't know which three are going to get cured and which seven are not. There's no way I can predict that.
The presentation of prognosis in this encounter has multiple features. A specific statement of prognosis is expressed in percentages (approximately a 20-25% chance of a long-term cure, there's a 75% chance that this won't be cured). That information is elaborated with explicit statements about the limits of treatment (we might be able to shrink it but not completely eliminate it) and the likelihood of recurrence (at some point, it will come back). This information is then followed by an explanation of why prognostic percentages cannot predict the course of disease for a specific patient (there's no way I can predict that). The second encounter that included a sustained discussion of prognosis included these two basic steps, but in slightly different form. This example came after staging information in Move 1, Step 2:
Excerpt 11
Physician: But if the melanoma spreads beyond the regional lymph nodes, the other areas of the body, or is to the point where it can't be removed surgically, it's generally to you guys Stage IV melanoma, and it's not viewed as a curable form of cancer. Just by saying that, there are a few patients that we've had in our practice over the years that have been fortunate enough to respond to treatment very dramatically and have had good outcomes for the long haul. But I would be misleading you to suggest that that were a regular occurrence. It's unfortunately a very irregular occurrence.
Here prognosis is presented in less direct and more binary form. Instead of specific percentages, the prognosis statement contains the negative form of an implied binary distinction (Stage IV melanoma is not . . . a curable form of cancer) and a one-directional elaboration of that information (a few patients . . . respond to treatment). The caution to the patient against a misleading application of prognosis information is also presented in binary fashion: The likelihood of good outcomes is not regular but irregular. Both these two encounters suggest, then, that the genre of treatment discussion can also be organized to foreground prognosis. A prognosis move in this genre would consist of two steps: a statement of prognosis, minimally or maximally elaborated, and a caution that prognosis is an unreliable predictor of an individual case.
Backgrounding prognosis. Excerpts 10 and 11 contrast in another way: in the directness or indirectness of the language. In excerpt 10, the physician uses notably direct language, reporting a specific percentage for the chances of cure and elaborating with a definite statement that the cancer will come back. The effects of the treatment are described with the direct word shrink (compared to the more euphemistic term control in excerpt 8). In excerpt 11, however, the physician uses more indirect language, which is indicated by a combination of linguistic features: The negative passive it's not viewed as and the wordy implied binary a curable form of cancer are not easy constructions to process; even the key word curable is an uncommon derived form. I argue that by using features of indirectness at the language level in combination with another feature of embedding at the genre level, physicians may only appear to do the work of presenting a prognosis, specifically by backgrounding the mention of prognosis. With this discourse practice, prognosis is implied rather than directly stated, and its meaning must be inferred, thereby making the status of prognosis unstable and uncertain within the genre of a treatment discussion in medical oncology.
Four features of indirectness characterize the sentence-level presentation of prognosis. As I have mentioned, one feature is euphemisms, the use of suggestive but ultimately undefined expressions, such as control, get ahead, and the real test:
Excerpt 12a
Physician: It has to be treated by some kind of chemotherapy to try to control it.
Excerpt 12b
Patient: Do you see-where that is-is that treatable? Physician: Well, it's definitely treatable. The question is can we get ahead of it in the long run? And that's a much tougher question.
Excerpt 12c
Physician: And the real test is how much does it shrink, and can we get it to disappear entirely?
Other euphemisms call upon military or sports analogies, some quite elaborate:
Excerpt 13a
Physician: There's a few people that have this disease that bullets won't stop it.
Excerpt 13b
Physician: There's no guarantee that we're going to totally be able to get rid of it, but we do have some ammunition.
Excerpt 13c
Physician As I have also mentioned, a second feature of indirectness is complexity at the level of words or syntax:
Excerpt 14a
Physician: It's generally to you guys Stage IV melanoma, and it's not viewed as a curable form of cancer.
Excerpt 14b
Patient: If this treatment were to work on me, it would essentially prolong my life-Physician: Correct. Prolongation. If you get a response to the treatment, then your life will be prolonged. . . .
Like curable in excerpt 14a, prolongation in excerpt 14b is an uncommon derived word form; moreover, both statements are also in passive form.
A third feature of indirectness in the language of prognosis is the use of vague quantifiers:
In looking at chemo and radiation, does it set it back for a year? Physician: It has a chance to cure it. Most people respond. . . . Some people get cured, with some people all of the disease disappears, and it never comes back again. [There's a] chunk of people in whom the disease shrinks dramatically, behaves itself for a while, then it starts to grow again later on. There's a few people who have this disease that bullets won't stop it. We give them treatment, and it just doesn't seem to work. Fortunately, that's pretty uncommon.
In this excerpt, three groups of patients are distinguished-those in whom all of the disease disappears, those in whom the disease starts to grow again later on, and those in whom bullets won't stop their disease. But every term quantifying these groups-a chance, most, some, a chunk, a few, pretty-is vague to the point that the likelihood of being in any one group cannot be determined with any certainty. The fourth feature of indirectness in the language of prognosis is vague descriptive language in general:
Excerpt 16a
Physician: Stage IIIB is the next stage below Stage IV, and it still represents a problem. It's a challenge to get rid of it.
Excerpt 16b
Physician: Actually, any time a tumor spreads to the lungs, it's bad news. And that's not an easy thing to get ahead of.
Although these expressions all imply a poor prognosis, they are not specific-How difficult a challenge? How bad is bad? How hard is not easy?
In most encounters with a physician-initiated mention of prognosis, the language of prognosis was not only indirect but also deeply embedded within another step in a move or in a transition between moves in the genre. For example, the prognosis information is embedded in the following treatment recommendations (Move 2, Step 1):
Excerpt 17a
Physician: We have some drugs that sort of work for abdominal cancer.
Excerpt 17b
Physician: If this is the only spot, then some very localized radiation would take good care of that.
Here the prognosis is embedded at the word or phrase level: The phrasal hedge sort of implies a poor prognosis, and the verb phrase take good care of implies a good one. Neither excerpt includes a direct prognosis statement. Furthermore, in both excerpts, the sentence in which prognosis is implied functions as a key step in the overall genre-a treatment recommendation-and thereby backgrounds the information about prognosis to the foregrounded information about treatment. In the continuing discourse, the treatment recommendation becomes the topic of discussion, not the prognosis. In another example, the prognosis is embedded within an elaboration of staging information (Move 1, Step 2): Here, the staging information (we called it Stage IIIB) is followed by background information about the staging system into which the vague description of prognosis is embedded (it still represents a problem). The prognosis information is elaborated in the next sentence, but again in an indirect construction using vague language (it's a challenge to get rid of it). The caution against applying a general prognosis to the patient's own situation (there's no guarantee we're going to totally be able to get rid of it) is combined with a military analogy transitioning to the treatment recommendation (but we do have some ammunition). The prognosis here is thus backgrounded to the foregrounded progression of the genre from staging information in Move 1 to treatment recommendation in Move 2. Consider, too, prognosis information that is embedded between moves:
Excerpt 19
Physician: All of your disease is still confined to the lung. . . . It falls under the category of IIIB. Now IIIB is treatable disease. The treatment is not the easiest thing in the world, but it's something that most healthy people can make it through. What it involves is getting chemotherapy and radiation together.
In this example, the prognosis statement (IIIB is treatable disease) is embedded as a transition between Move 1, Step 2 and Move 2, Step 1, having equally strong cohesive ties to both steps-IIIB refers back to staging information, and treatable disease refers ahead to the forthcoming treatment recommendation. Because the statement of prognosis is deeply embedded as a transition between moves, it is thereby backgrounded. I argue that embedding prognosis in a step or, especially, in a transition between moves provides a means of backgrounding a prognosis, a backgrounding that can be further accomplished through the use of indirect language. This backgrounding may provide physicians with a way to appear to do this difficult work without making it a foregrounded move in the genre, thereby allowing the import of prognosis to be missed in a dense presentational oral genre. Thus, by embedding information and using indirect language, physicians are able to claim that they presented a prognosis, but they cannot be reasonably assured that the patient foregrounded-that is, heard, comprehended, and remembered-the information.
Answering questions about prognosis. One final argument that prognosis is not a predictable move in the genre of treatment discussion comes from the questions asked in Move 3. I noted earlier that physicians and families seem to use the interactional Move 3 to coconstruct a full version of the treatment discussion genre, noting that if a step such as side effects is not mentioned in the presentational discourse of Moves 1 and 2, patients or their families will ask a question about the topic. That is also true about prognosis, and in a notable way: Of the four encounters in which physicians did not mention prognosis, two families asked about prognosis in Move 3. Of the eight encounters in which prognosis was mentioned in the treatment discussion, four families asked further questions about prognosis. Overall, then, half of the patients and families used Move 3 to address prognosis, either initially or in follow-up discussions. No other kind of question appeared so consistently in Move 3, indicating that the other users of the genre-patients and families-construct the genre of the treatment discussion to include prognosis.
When patients or families ask for prognosis in Move 3, they receive an answer that incorporates the two steps described earlier-a prognosis statement, minimally or maximally elaborated, and a caution against applying it to their own situation. Consider the following exchange from the encounter discussed in excerpt 8, in which the physician did not mention Stage IV disease or prognosis:
Overall, what success rate do you have? Physician: Well, the chemotherapy, in most people, will help slow the growth of the tumor. In probably, depending on what regimen you select, anywhere from 20-50% of the time it will help shrink it down substantially. But it's unlikely to get rid of it entirely. Patient:
The liver has tumors, right? Physician: Right. The chemotherapy hopefully will keep it under control for a time, but it won't prevent it. And eventually, it'll grow despite treatment. The tumors become resistant to treatment. But that could be months from now, it could be weeks from now, it could be years from now. Patient:
Well, I'm glad you were straightforward with that because I was wondering, you knowThis question triggers a full-featured discussion about prognosis with fairly direct language, including percentages elaborated with explicit statements about the limits of treatment and ending with a caution about the unpredictability of prognostic information. The patient closes the exchange by acknowledging that she wanted straightforward information about prognosis. Other Move 3 exchanges about prognosis were similar, and physicians' answers to questions about prognosis seem to indicate consid-erable awareness of the features of the presentation of prognosis. For example, the most common form of a question about prognosis concerned life expectancy: In this example, the physician overtly reverses the usual order of the two steps in presenting a prognosis but with an indication that he realizes his answer is somewhat marked. He begins with a caution, perhaps as a matter of emphasis (well, it does become very unpredictable), but interrupts himself by promising to give some figures to work with, information usually included in the first step in presenting a prognosis. Conversation analysts would note that the participants in this excerpt seem to be paying attention to their own versions of the genre (Drew & Heritage, 1992) . In her question, the patient interactively constructs her version of the treatment discussion genre as one that addresses prognosis. In his answer, the physician provides a full presentation of prognosis. He reverses the order of the two steps, but not without paying interactional attention to the marked version of his answer. Also, after providing the actual numbers for average life expectancy, the physician then goes on to recursively repeat the steps of the prognosis move, noting that the prognostic predictions of average life expectancy can be changed considerably, and elaborating by adding that a small percentage go into remission. He ends with yet another version of the caution against using the percentages given for prognostic purposes to predict the course of the patient's own disease. Excerpt 21 is thus a doubled version of the prognosis move, a repetition that indi-cates considerable awareness of the steps that are available for manipulation within the move of presenting a prognosis.
In sum, the steps in a treatment discussion that presents a prognosis appear to be repeated and recognizable across the corpus, but prognosis has not become a predictable move in the overall organization of the genre of treatment discussions. One obvious reason for that has been mentioned: If patients are not definitively diagnosed and staged, discussion of prognosis is inappropriate in the treatment discussion. The genre thus requires a certain degree of flexibility with respect to prognosis. But this flexibility cannot be the whole story, given that questions in Move 3 provide strong evidence that the patient and families do interactional work in order to coconstruct the genre of treatment discussions to include prognosis. This flexibility, in fact, can become problematic because it also allows prognosis to be avoided or backgrounded. This problematic nature of prognosis in front-stage treatment discussions is further evidenced by noting the prominence of prognosis as a topic in back-stage conversations.
Prognosis in Back-Stage Conversations
The discourse features of front-stage prognosis were its unpredictability within the moves and steps of the treatment discussion genre, its deep embedding within and between moves, its indirect language, and its representation as unreliable. In contrast, the features of backstage prognosis are completely the opposite.
I gathered data for a discourse analysis of back-stage conversations from field notes about a set of 33 patient encounters (31 encounters with patients that included back-stage exchanges plus back-stage comments about two no-show appointments).
1
These data included a total of 65 back-stage conversations-primarily exchanges between physicians and me as an observing researcher although other physicians, extenders, nurses, and staff members were sometimes present.
2
By far the largest category of topics concerned medical matters (N = 29), either diagnostic (n = 13 exchanges, e.g., I don't know what this guy has) or prognostic (n = 12 exchanges, e.g., The news won't be good), with an occasional comment about cancer in general (n = 4 exchanges, e.g., Melanoma, I will tell you, is a bad, bad disease. There's no escaping it). These comments were generally negative: Physicians commented about being uncertain of a diagnosis or stage or about suspecting a poor prognosis. Thus, prognosis was a fairly predictable topic of backstage conversations, particularly in the case of bad news. Of the 12 encounters in the corpus for the genre analysis, three patients had early-stage disease (Stages I and II), and physicians made no backstage comments about their prognoses; of the nine patients with advanced disease (Stages III and IV), physicians commented about the prognoses for six.
Other features of back-stage prognosis exchanges were in contrast to the discussions on the front stage. First, in contrast to the generic embedding of prognosis into other moves and steps of the treatment discussion, back-stage talk about prognosis was not embedded into other topics. In fact, talk about prognosis usually consisted of single utterances or short exchanges, usually the first comment after coming out of a clinic room or after reviewing records and scans (e.g., She's at ridiculously high risk for reoccurrence). Back-stage prognosis talk, then, was almost always initiated by physicians themselves, again unlike front-stage discussions, in which patients and families sometimes have to broach the topic.
In contrast to the indirectness of prognosis language on the front stage, back-stage talk about prognosis used direct language. Direct terms about death and dying were not uncommon back stage (e.g., [Otherwise] she'll be dead from a miserable disease). Sometimes back stage talk about prognosis contained analogies, but these were oriented negatively, not positively as on the front stage (e.g., Otherwise it's just rearranging deck chairs on the Titanic). Gallows humor was also common, especially between physicians looking at scans (e.g., What's that big thingee?). Sympathy was also often expressed in direct-even crude-terms (e.g., She's got ugly disease. You can see that mass in there.
That sucks).
Finally, in back-stage conversations, talk about prognosis was presented as reliable, contradicting the front-stage caution against prognosis being a reliable predictor of an individual case. Back stage, disease was described in definite terms with no qualifiers or implications that individual cases are variable (e.g., He's got bad disease. Young, too. Only 42) . In contrast to the euphemistic presentation of prognosis on the front stage (e.g., The question is, can we get ahead of it in the long run, and that's a much tougher question), back-stage talk about prognosis was plain and definite (e.g., [That's] 
a big ugly mass that's not going to go away soon).
The features of talk about prognosis on the back stage were almost directly opposite those on the front stage. On the front stage, the topic of prognosis was not predictable; it did not occur as a predictable move or step in the genre of treatment discussion. Often patients and families initiated the topic of prognosis in their coconstruction of the genre of treatment discussion. On the back stage, however, the topic of prognosis was predictable in the case of bad news, and it was initiated by physicians themselves. On the front stage, prognosis was usually presented with features of indirectness and deep embedding. On the back stage, prognosis was presented in direct language, in first exchanges specifically devoted to the topic. On the front stage, physicians cautioned patients and families to consider prognosis information to be unreliable predictors of individual cases. On the back stage, however, prognosis was presented as reliable.
Prognosis, in sum, was foregrounded on the back stage yet often backgrounded-if mentioned at all-on the front stage. I suggest that the attention to prognosis on the back stage reflects the experience of medicine, particularly the preponderance of negative experience in cancer medicine, along with some of its resultant frustration. This articulation of experience in back-stage conversations directly, rather than indirectly, reflects the expected realities of prognosis for advanced disease.
CRITICAL QUESTIONS
Genre analysis and discourse analysis are methods that provide a descriptive basis for developing, as Segal et al. observed (1998) , "a growing appreciation of the complexity of the [professional] discourse" (p. 80). These analyses have shown that both the genre of treatment discussions in medical oncology and its contrasting discourses of front-stage and back-stage prognosis incorporate a considerable degree of complexity. With this complexity in mind, a discoursebased methodological approach goes from descriptive questions about how the discourse is arranged to critical questions about why it is arranged as such:
1. Why is this front-stage genre of treatment discussions an oral one? 2. Why are the features of the discourse of prognosis so different on the front stage than on the back stage? 3. How is the discourse of prognosis connected to the medical profession and its interested performance of social work? 4. How might a critical analysis of these connections contribute to a deeper understanding of the problematic nature of the discourse of prognosis on the part of rhetorical researchers and medical practitioners?
I argue here that the organization and use of this oral genre and its discourse of prognosis are multiply determined by a number of emic concepts and categories within the medical profession, showing how the organization of the discourse "is situated in its discursive relations, the complex relations among writers [speakers] and readers [hearers] which support and constrain its textuality" (Wells, 1996, p. 2) . Laying out these connections between emic categories and discursive practices thereby creates what Wells calls "some space for critical thought" (p. 99).
In response to my first and second questions, I have shown above that the organization of the treatment discussion as an oral genre allows prognosis to be an unstable feature on the front stage, one that users of the genre can foreground, background, or avoid. I have also shown that the back-stage discourse of prognosis, with its characteristic directness, contrasts with the front-stage discourse of prognosis and points to its more problematic indirectness. In this section, I work primarily on the third question, connecting prognosis as a problem in the discourse of medicine to complex and conflicted emic categories within the profession of medicine, both past and present. In making these connections, I rely on a combination of writing about medicine as well as my experience as an observational researcher in medical clinics. In looking to the vast literature of writing about medicine, I draw on accounts written by physicians as well as on standard textbooks, following Kuhn (1962) , who argued that these kinds of sources serve both intellectual and institutional purposes. Kuhn noted that these sources articulate the received version of the field: "As the source of authority, I have in mind principally textbooks of science together with [their] popularizations" (p. 136). Textbooks, especially, help to socialize new members of professional communities: "These textbooks expound the body of accepted theory," Kuhn suggested, and "prepare the student for membership in the particular scientific community with which he will later practice" (pp. 10-11). These sources, then, are places to look for preliminary articulations of some of the emic categories of the field that drive both the front-stage and back-stage discourses of medicine.
One historical answer to the question of why the treatment discussion is an oral genre comes from the origins and development of the profession. As Wells (2001) and other medical historians have explained (Porter, 1999) , the delivery of medicine through talk is one of the oldest dimensions of the profession. Furthermore, talk, particularly in 19th-century medicine, was an integral part of the cure the profession offered:
The medical practice [of the nineteenth century] . . . was one which valued talk. Medicine was therefore a heavily discursive practice, worked out patient by patient in a series of conversations. Conversation initiated treatment, and conversations marked its progress. . . . The doctor's talk to the patient, however, was always a feature of treatment. . . . [Talk] was seen as essential to the cure. . . . [T]he medical interview was the central discipline of therapy rather than ancillary to it. (Wells, 2001, p. 16) Despite the development of medicine into a more technical field that now looks more to physical examination and tests for diagnosis and to medication and procedures for treatment, the element of talk nevertheless remains central to the profession in establishing diagnosis and recommending treatment.
In the domain of diagnosis, talk has necessarily remained central to the contemporary medical interview, and medical students are explicitly taught how to take a medical history from a patient and turn it into a case presentation for other physicians. A multitude of books for medical students purport to teach the process (e.g., Aldrich, 1999; Billings & Stoeckel, 1999; Coulehan & Boch, 2001; Schryer et al., 2003) ; however, more accurately described this process in terms of apprenticeship, noting that "medical students must be socialized into the 'habitas' or ways of perceiving, behaving and communicating characteristic of their profession. . . . [T]hese neophyte practitioners must immerse themselves in the social practices of their discipline" (p. 63).
Presumably the same should be true for medical students learning about treatment discussions and the presentation of prognosis, but the opposite seems to be the case. Groopman (2002) is representative of many physicians when he noted that the formal education of medical school largely ignores the presentation of prognosis and further observed that the apprenticeship process is disrupted for prognosis as well:
During my nine years of medical school and professional training in the nineteen-seventies, I was never instructed in how to speak about dying to a gravely ill patient and the patient's family. It was presumed that, as medical students, we learned how to deliver bad news through careful observation of our mentors. . . . But most physicians preferred to speak to their patients [about this] in private. (p. 64) In textbooks, physicians-in-training are actually warned against delivering prognosis information to patients, lest it be premature; the venerable Harrison's Principles of Internal Medicine, for example, cautions that the harm that a physician can do to a patient is not limited to the imprudent use of medication or procedures. Equally important are illconsidered or unjustified remarks. Many a patient has developed a cardiac neurosis because the physician ventured a grave prognosis on the basis of a misinterpreted noninvasive cardiac examination. Not only the treatment itself but the physician's words and behavior are capable of causing injury. (Wilson et al., 1991, p. 4) The danger of language is thus connected specifically to the presentation of prognosis. No wonder physicians-in-training might be tempted to avoid or background the presentation of prognosis, given received wisdom like that in the first section of a major textbook for the field.
Such an attitude is further reinforced in clinical experience as well, as Groopman (2002) noted. Experienced physicians, while not particularly worried about making errors in prognosis, nevertheless speak of its presentation as problematic in clinical settings. My physician informant made the following remark one day in the clinic work area, in the presence of training fellows and staff:
It's a no-win situation. If you have someone with incurable disease, and you don't talk about it, then when he doesn't do well the family says you didn't tell them how bad it was. But if you tell them, then you get a letter from the family the next week that says the patient is all depressed. (Barton, 2002) Unlike the more or less settled place of language in presenting a diagnosis, then, the place of language in presenting a prognosis arouses a deep ambivalence that is pervasive in the literature and practice of medicine, especially in its training.
One reason for the ambivalence of the profession toward presenting a prognosis is its potential to disrupt the doctor-patient relationship. The doctor-patient relationship is a central category of the profession of medicine (similar to the teacher-student relationship that is foundational in composition studies or the researcher-researched relationship that is currently the topic of much attention in ethnography). Much has been written about the doctor-patient relationship, both inside and outside the field of medicine (Aldrich, 1999; Brody, 1992; Cassell, 1997; Katz, 1984 Katz, /2002 Kleinman, 1988; Roter & Hall, 1992; Starr, 1982) . As Parsons (1951) noted in one of the seminal works in medical sociology, the doctor-patient relationship is an individual, personal, and transactional one, with significant material and social consequences; it is a relationship based primarily on expertise and warranted by the social contract of the professions to deliver such expertise ethically (Freidson, 1986; Haskell, 1984; Larson, 1977) . More critically, Starr (1982) argued that the doctor-patient relationship is one of dependence and expertise that preserves the power and autonomy of the medical profession. In other words, the medical profession (perhaps like other professions) develops practices, including discourse practices, that maintain its social power, prestige, and privilege, and the doctor-patient relationship can be seen through this critical lens as well.
Within the profession itself, however, most discussions of the doctor-patient relationship present an idealized form, as in the following example from the first page of the massive Harrison's Principles of Internal Medicine:
It may be trite to emphasize that physicians need to approach patients not as "cases" or "diseases" but as individuals. . . . The physician needs to consider the terrain in which an illness occurs-in terms not only of the patients themselves but also of their families and social backgrounds. . . . Without this knowledge it is difficult for the physician to gain rapport with the patient or to develop insight into the patient's illness. Such a relationship must be based on thorough knowledge of the patient and on mutual trust and the ability to communicate with one another. (Wilson et al., 1991, p. 1) In such idealized descriptions, communication is almost always identified as an essential dimension of the doctor-patient relationshiphere depicted as a tripod of knowledge, trust, and communication. As shown in the discourse analysis presented here, however, medical communication is no straightforward or trustworthy matter with respect to prognosis, with the expertise of the profession systematically obscured by the indirectness of its front-stage discourse practices of prognosis. This obfuscation may happen in part because the knowledge and expertise of the profession are often frustratingly powerless in the face of advanced disease. Presenting a patient with a poor prognosis thus injects a material breach into the doctor-patient relationship, which, in its ideal form, is based on expertise that leads to treatment and cure-not to treatment with uncertain outcomes, including the possibility of death. A poor prognosis is disruptive to the foundations of the doctor-patient relationship; hence, its discourse is predictably a problematic one. The construct of the doctorpatient relationship, as observed by many physicians as well as critics, does not extend to incorporate incurable disease or the end of life well (Cassell, 1976; Groopman, 2002; Mattingly, 1998; Nuland, 1993; Quill, 2001) .
Physicians themselves are aware of the conflicts and complexities in presenting a prognosis in the case of serious disease. The topic is important enough to appear in the first section of Harrison's, which again presents a conflicted version of prognosis and its disclosure in the medical encounter:
No problem is more distressing than that presented by the patient with an incurable disease. . . . Although some would argue otherwise, there is no ironclad rule that the patient must immediately be told "everything." . . . How much the patient is told should depend upon the patient's ability and capacity to deal with the possibility of imminent death; often this capacity grows with time, and, whenever possible, gradual rather than abrupt disclosure is the best strategy. . . . The patient must be given an opportunity to talk with the physician and ask questions. (Wilson et al., 1991, p. 4) Note the agentless passive in the final sentence-when reinterpreted, the physician's communicative responsibility appears to be simply to allow communication about prognosis to happen; the initiation of talk and questions appears to be shifted to the patient (to Move 3 in the genre analysis).
Physicians tell stories about their move to indirect discourse practices of prognosis:
As an oncology fellow, I began my career believing that it was essential to provide details to my patients. Sharing statistics seemed like the obvious thing to do: surely a patient should have access to everything I knew. . . . [I met with my patient Claire] in my clinic office, and she looked at me expectantly.
"Claire, with this disease, a remission would ordinarily last three to six months," I told her bluntly. "A person could expect to survive between one to two years." She appeared to take the news stalwartly, but I later learned from her husband that she had left the appointment deeply shaken. . . . Her face was full of despair whenever I saw her. And yet Claire lived for nearly four years. She was able to travel, work part time, and take care of her children, but was unable to stop thinking that she could die at any moment. (Groopman, 2002, p. 64) Experiences like that, Groopman noted, led him to ask about future patients, "How much did [they] want to know?" (p. 66). Similarly, Nuland (1993) noted after a story of his own, "I have always tried to set the stage for patients to ask for full disclosure" (p. 236).
If, as Hunter (1991) argued, doctors' stories articulate the way that "the anecdotes of an expert have scientific status" (p. 31), then the indirect discourse of prognosis achieves at the least the status of good clinical practice. Physicians are thereby licensed through professional sources and clinical experience to avoid or background prognosis and default to the communicative option of simply waiting for questions from patients and families rather than risk a decision about appropriate (or inappropriate) disclosure. The burden of communicating about prognosis is thus shifted to patients and families. While some patients and families seem to intuit this and coconstruct the genre of treatment discussion to include prognosis via their questions in Move 3, perhaps not all patients and families are aware that they must take this communicative initiative in medical encounters-especially if they hold the contrasting expectation that the physician is responsible for being frank and forthcoming in medical communication generally and in matters of prognosis specifically.
The preceding discussion indicates that multiple emic categories of the profession-the historical and contemporary emphasis on language and communication, the idealized construct of the doctorpatient relationship, and the pervasive articulation of ambivalence with respect to the presentation of prognosis-contribute to the problematic status of the front-stage discourse of prognosis. Other emic categories could be considered as well. For example, the discourse of prognosis in a particular encounter could be a strategy for physicians to preserve efficiency; as Dunmire (2000) observed, physicians make real-time decisions to lengthen or shorten medical appointments, and avoiding or backgrounding prognosis could be a way of managing clinical time. The discourse of prognosis also could be aimed at maintaining a more pernicious separation between what Mishler (1984) called the medical world and the life world. In the patient's life world, prognosis, especially a poor prognosis, could be the center of a com-plicated emotional response; avoiding or backgrounding prognosis may allow the physician to avoid or background the patient's complicated (and time-consuming) emotions as well, in effect, ruling them out of the domain of the clinical encounter (Waitzkin, 1991) . Another consideration is the current medicolegal context of medicine, in which litigation is always a possibility from every encounter. Preserving the treatment discussion as an oral genre and discussing prognosis primarily in indirect terms could be a strategy of exhibiting professional caution (Drew & Heritage, 1992) : What is said in the treatment discussion and what is implied in the presentation of prognosis are less reliably available for legal proceedings.
One additional emic category of the medical profession, however, specifically drives the discourse of prognosis-the category of hope. Hope is one of the most powerful and most conflicted categories of the medical profession. In a classic text of the medical humanities, physician and medical humanist Cassell (1991) The loss of hope is thus connected to the worst of human suffering.
The specific connection between hope and prognosis has long been noted in writing about medicine. A famous bit of advice about prognosis came from William Osler, widely recognized as an authoritative voice in the history and development of the medical profession in the 20th century; this quote is featured prominently in Harrison's: "One thing is certain; it is not for you to don the black cap and, assuming the judicial function, take hope away from any patient . . . hope that comes to us all" (Wilson et al., 1991, p. 4) . Nuland (1993) told an extended story about following this advice in not disclosing the prognosis to his brother who was dying of cancer:
As Harvey recovered from the operation's assault, I grappled with the twin issues of truthfulness and treatment. . . . With this burden on my shoulders, I made a series of mistakes. . . . I became convinced that telling my brother the absolute truth would "take away his only hope." . . . At no time did I ever consider sharing with him what I knew to be the virtually certain prognosis that he would not survive until summer. In every way, I had returned to the misconceived paternalistic dictum of the professors who taught me a generation ago: "Share your optimism and keep your pessimism to yourself." (pp. 225-228) Nuland summed up his ambivalence with another version of Osler's saying: "A young doctor learns no more important lesson than the admonition that he must never allow his patients to lose hope" (p. 222).
I argue that the emic category of hope has both rhetorical and material complications and consequences with respect to the discourse of prognosis. Presenting a poor prognosis is widely regarded by physicians as destroying (or at least having the potential to destroy) a patient's hope, and destroying hope is considered a breach of humane medical care. Thus, the indirect discourse of prognosis is based on more than the historical paternalism of the medical profession or the arrogant preservation of professional knowledge for the convenience and privilege of practitioners. It also goes beyond the all-too-human unwillingness to be the bearer of bad news. In this view, indirectness is part of the delivery of compassionate medical care, care that addresses the emotional life world of the patient, albeit indirectly, by preserving hope. One family informant who reviewed this article pointed out that the mention of prognosis was indeed "elided, buried, and marginalized" in their series of oncology encounters, but he also noted that the preservation of hope was part of their ongoing experience of cancer: "Whether it's old-fashioned paternalism or newfashioned compassionate care, it produces the same effect" (Barton, 2002) . The problem that indirectness allows, however, is the creation of false hope. By avoiding or backgrounding the prognosis, physicians leave open the possibility that patients and their families will interpret their indirect discourse as a basis for hope when hope is not warranted.
An additional rhetorical complication of hope as it drives the discourse of prognosis is that patients and their families may define hope differently than do physicians. As we have seen, patients and their families often construct the genre of treatment discussion to include prognosis. Their queries and comments about prognosis express a sense of hope in general terms of survival or in more specific terms of time left:
Overall, what success rate do you have?
Excerpt 22b
Patient:
In looking at chemo and radiation. Does it set it back for a year? If hope is present within these utterances, it seems to be conceptualized in the material binary of survival until death. But physicians, especially in the face of advanced disease, conceptualize hope not in general terms of survival but in more limited terms of control of the tumor. Their presentation of prognosis is thus often connected to treatment:
Excerpt 23a
Physician: It has to be treated by some sort of chemotherapy to try to control it.
Excerpt 23b
Excerpt 23c
Physician:
We have approximately a 20-25% chance of a long-term cure. Despite doing all this [treatment] .
Excerpt 23d
Physician: There are a few patients . . . that have been fortunate enough to respond to treatment very dramatically and have had good outcomes for the long haul.
Excerpt 23e
Physician: And the real test is, How much does it shrink, and can we get it to disappear entirely?
For physicians, this more limited conceptualization of hope supports the decision to treat. And when treatment works, it is the right material decision: Groopman's patient Claire, for instance, lived to care for her children for 4 more years, and every oncologist has stories of patients who defied prognostic odds, went into remission, or even were cured of advanced disease (that 1, 2, 3, 4, 5% who might go into remission). We cured him is not an unusual back-stage comment from a physician after seeing a patient who is disease-free 3 years or more after treatment (the number of years a patient must be disease-free to be declared cured varies with types of cancer; 3 years is the window for advanced lung cancer). But treatment does not always work to control cancer. One of the unfortunate material consequences of physicians' conceptualization of hope is that it can support the decision to undertake futile treatment, as Nuland (1993) argued:
Sometimes it is really to maintain his own hope that the doctor deludes himself into a course of action whose odds of success seem too small to justify embarking on it. . . . He indulges a very sick person and himself in a form of medical "doing something" to deny the hovering presence of death. (pp. 223-224) The hope of physicians to achieve control over cancer can thus result in excessive treatment at the end of a patient's life.
After reading a version of this analysis, my physician informant observed that "the job of a medical oncologist is to balance realism and hope" (Barton, 2002) . I believe that this discourse analysis can contribute to achieving this balance. Specifically, I propose that attending to the back-stage discourse of prognosis is a way of pointing to the need to balance these competing categories of realism and hope. Back-stage discourse is an articulation that seems to be facilitated by the presence of an observational researcher as a sort of insider, but I would suggest to physicians that these comments may be more than just polite or meaningless conversation. By making physicians more conscious of the importance of their experiential assessment and its connection to the balance of realism and hope in medical encounters, a critical analysis of back-stage discourse can make an important contribution to an area of medical communication that physicians consider difficult. Physicians make back-stage comments about a prognosis specifically when it is troubling; this back-stage discourse is thus a signal that the balance of realism and hope is relevant for the care of a particular patient. If physicians can be trained to pay attention to their back-stage comments or reactions concerning prognosis, articulated or not in a given instance, they may be less inclined to fall into the default discourse practices of avoiding or back-grounding prognosis and shifting the communicative responsibility for prognosis to patients and their families. If back-stage discourse expresses experience in the absence of false hope, such realism could (and perhaps should) recursively enter the front-stage discourse of prognosis. By attending to their back-stage discourse, physicians may, at least, be impelled to reassess their front-stage discourse that may lead to the rhetorical pitfall of creating false hope and the material pitfall of pursuing futile treatment. The back-stage discourse of prognosis could thus function to articulate the experiential conscience of practitioners as they conduct treatment discussions fraught with the rhetorical and material dilemmas of prognosis.
CONCLUSION
In this article, I used a set of descriptive methods from linguistics to lay a detailed ground for critical analysis, a project that was just started in this discussion. I made the methodological argument that combining a description of a discourse and a consideration of its connections to the emic categories of a profession lays a multiply determined ground for a critical analysis. I submit that this methodological trajectory-the description of the complexities of the discourse and the connection to its multiply determined emic categories-must be taken into account for critique that has the potential to generate meaningful ideas for change in a professional community. By enlarging our ground to include the profession as well as the discourse, our critical engagement will not only be richer but also be more likely to ring true to the audience of the discipline as a basis for change.
That is the approach I take when I present discourse research to medical practitioners in an effort to establish a mutual understanding of professional practices and, perhaps, move toward critically informed changes in those practices. I present enough details of the discourse to show that the patterns are real and recognizable, thereby justifying the methodological approach as one that brings unique and valuable knowledge to the profession, knowledge that helps practitioners see the ways in which their discourse practices manage difficult topics and avoid disrupted doctor-patient relationships. Then, as a way to open discussion, I recount exactly what I discovered in terms of the emic categories of the profession. The practitioners inevitably assure me that Harrison's (or whatever I cite as a source of received wisdom written by and for the profession itself) is oversimplified, and we then move on to identifying and describing complex categories such as hope in more detail, allowing us to work together against an uncritical sense of the profession, its history, its training, its key categories, and its discourse practices. This critical and theoretical exploration of complex categories is thereby motivated by my research as well as their articulation of the profession. Our critical engagement can thus facilitate collaborative discussion toward critically informed change. This approach could, perhaps, be regarded as theory hope (Fish, 1989) , but I prefer to think of it as the discourse-based beginning of interdisciplinary critical practice.
NOTES
1. The corpus numbers for the front-stage genre/discourse analysis are different from the corpus numbers for the back-stage discourse analysis. When I was conducting field research in the cancer center, I observed a variety of encounters-appointments with new patients, second opinions, appointments with patients in active treatment, and follow-up appointments with patients who had finished treatment. To develop a sense of back-stage discourse in general (see note 2), I analyzed comments from all of these different encounters. To develop a genre analysis of treatment discussions and a discourse analysis of front-stage prognosis, I had to draw from a more limited number of encounters with new patients.
2. A topical analysis of the back-stage exchanges revealed the following categories and instances:
• Comments about medical opinions ( n = 29) • Comments about patients as research subjects (n = 8) Positive (3) Negative (5) • Comments about previous mismanagement (n = 7)
• Comments about office politics (n = 3) 3. There is an emerging literature in medicine on what is called "breaking bad news" (Buckman, 1992) although it has much ground to overcome, given the established wisdom presented in textbooks like Harrison's (Wilson et al., 1991) . I must leave a consideration of the "bad news" literature for a future project.
